Johnson & Johnson to Participate in the Piper Jaffray 23rd Annual Health Care Conference

NEW BRUNSWICK, N.J., Nov. 28, 2011 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Piper Jaffray 23rd Annual Health Care Conference on Tuesday, Nov. 29th at The New York Palace, New York, NY.  Gary Pruden, Company Group Chairman, Ethicon will present in a session scheduled at 8:00 a.m. (Eastern Time).

The webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

  

 

 

SOURCE Johnson & Johnson

Suggested Articles

German viral vector CDMO Vibalogics has hired Lonza veteran Tom Hochuli as global CEO to help lead its U.S. expansion efforts.

Merck’s Keytruda already boasts an OK in some esophageal cancer patients, but it’s looking to widen its reach in the tough-to-treat disease.

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opdivo has broken through with two potentially practice-changing trials.